Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
PTCT
$63.49
+0.21%
PTCT
· Ptc Therapeutics, Inc.
$63.49
+0.13 (+0.21%)
At close · Nov 13
View the 10-K filed Feb 19, 2026
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Customer concentration
— top 4 customers 10% of revenue
4 customers — 10% of revenue (2025)
“During 2025, four of our distributors each accounted for over 10% of our net product sales.”
Market Cap
$5.30B
Shares
83.54M
Volume · Nov 13
502.9K
Avg daily vol (3M)
1.07M
All webcasts
Earnings call · FY2019 Q4
Ptc Therapeutics, Inc. (PTCT) Q4 2019 Earnings Call
Revenue · derived Q4
$96.46M
+12.4% YoY
Gross margin · derived Q4
96.3%
+0.7 pp YoY
Net income
-$77.68M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Jan 13, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 2, 2020 · complete as-filed document